Shi Si Yao Group: Drugs such as low-calcium peritoneal dialysis fluid have obtained production registration approval
2026-11-19 13:00:20
According to CoinMeta, Shisiyao Group (02005.hk) has issued a announcement stating that it has obtained the drug production registration approvals from the China National Medical Products Administration for low-calcium peritoneal dialysis fluid (bicarbonate g1.5%), peritoneal dialysis fluid (bicarbonate- g2.5%), peritoneal dialysis fluid (bicarbonate- g4.25%), and low-calcium peritoneal dialysis fluid (bicarbonate- g4.25%). These products are all available in a 2000ml specification and fall under Class 3 of chemical drugs, and are considered to have passed the consistency evaluation. Among them, the low-calcium peritoneal dialysis fluid (bicarbonate- g4.25%) is the third product of its kind approved by a domestic company. These products are mainly used for peritoneal dialysis in patients with chronic renal failure and are used when hypermagnesemia has not been adequately improved.
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.
Follow WalletJYS official accounts to stay updated

Hot Articles
Refresh

What Is Bitmine? Why the Largest ETH Treasury Halted Buys
11-17 11:29

NVIDIA's stock tumbles 9% after the latest announcement; what impact will NVIDIA's decline have on the AI industry?
11-12 16:08

Is the Tangem wallet secure? No need to memorize a mnemonic phrase, can beginners use it with confidence?
11-12 17:31

SOL Currency's Latest Price Outlook: Can It Break Through the $90 Barrier?
11-11 11:59

Dow Jones 1,000-Point Swings: CPI Reversal or Bull Trap?
11-10 16:56



